-
Subgroup analysis.
MPVT: main portal vein thrombosis; PVBT: portal vein branch thrombosis; TEM: extrahepatic metastasis; PVT: portal vein thrombosis. -
r37980778c78--376efb460460ecde52c4dbdb22287cb1
Correlation between the MMSE-2 and cognitive measures. -
r37980778c78--4e44e005eef68959aefcb14d5ff8c47a
Several metrics of analysis of magnetic resonance imaging (MRI) have been used to assess Alzheimer’s disease (AD)-related neurodegeneration. We compared four structural brain... -
BDNF levels of different point times and antidepressant treatment.
BDNF levels of different point times and antidepressant treatment. -
r37980778c78--ae83b9b2853bbde3191a9da3589f9aa4
Risk factor analysis of osteoporosis in patients with atopic dermatitis. -
Top 20 treatment patterns (LOT 1 to LOT 3) for 1<sup>st</sup> treated TRD epi...
Top 20 treatment patterns (LOT 1 to LOT 3) for 1st treated TRD episodes. -
Demographics and clinical characteristics of Korean male participants in stud...
Demographics and clinical characteristics of Korean male participants in study 2. -
r37980778c78--0e1cab387a0585d7e506cd86941ca780
Correlation between quality of life (IDQOL/CDLQI) and severity of atopic dermatitis (TIS), according to age groups. -
r37980778c78--1ec0046b5acb9e0ce84d4b45827c2759
Baseline Demographic Characteristics of the Current Sample. -
r37980778c78--727d7311c2dff12ee3573568c259f435
Pearson correlations between annual percent change (APC) and age. -
The results of the MMSE-2:EV in the three groups (M±SD).
The results of the MMSE-2:EV in the three groups (M±SD). -
AD change in white matter tracts and working memory change.
AD change in white matter tracts and working memory change. -
Characteristics of included studies.
RCT: Randomised controlled trial. GS: Gilead Sciences. R: Roche. GSK: GlaxoSmithKline. NS: not stated. aCopies/mL converted to IU/mL by dividing by 5.bThe limit of detection of... -
Proton pump inhibitor use does not increase dementia and Alzheimer’s disease ...
Recent studies have indicated an increased risk of dementia and Alzheimer’s disease (AD) among people who consume proton pump inhibitors (PPIs), but the results of those studies...